Trait: non-Hodgkins lymphoma

Experimental Factor Ontology (EFO) Information
Identifier EFO_0005952
Description Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage. [NCIT: C3211]
Trait category
Cancer
Synonyms 5 synonyms
  • NHL
  • non-Hodgkin lymphoma
  • non-Hodgkin's lymphoma
  • non-Hodgkin's lymphoma (NHL)
  • non-Hodgkins lymphoma
Mapped terms 11 mapped terms
  • DOID:0060060
  • EFO:0005952
  • GARD:11953
  • ICDO:9591/3
  • MESH:D008228
  • MONDO:0018908
  • MedDRA:10029547
  • NCIT:C3211
  • ONCOTREE:NHL
  • Orphanet:547
  • UMLS:C0024305
Child trait(s) 6 child traits

Associated Polygenic Score(s)

Filter PGS by Participant Ancestry
Individuals included in:
G - Source of Variant Associations (GWAS)
D - Score Development/Training
E - PGS Evaluation
List of ancestries includes:
Display options:
Ancestry legend
Multi-ancestry (including European)
Multi-ancestry (excluding European)
African
East Asian
South Asian
Additional Asian Ancestries
European
Greater Middle Eastern
Hispanic or Latin American
Additional Diverse Ancestries
Not Reported
Note: This table shows all PGS for "non-Hodgkins lymphoma" and any child terms of this trait in the EFO hierarchy by default.
Polygenic Score ID & Name PGS Publication ID (PGP) Reported Trait Mapped Trait(s) (Ontology) Number of Variants Ancestry distribution Scoring File (FTP Link)
PGS000080
(CC_NHL)
PGP000050 |
Graff RE et al. Nat Commun (2021)
Non-Hodgkin's lymphoma non-Hodgkins lymphoma 19
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000080/ScoringFiles/PGS000080.txt.gz
PGS000641
(PRSWEB_PHECODE202.2_GWAS-Catalog-r2019-05-03-X202.2_P_5e-08_UKB_20200608)
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Non-Hodgkin's lymphoma non-Hodgkins lymphoma 12
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000641/ScoringFiles/PGS000641.txt.gz
PGS000642
(PRSWEB_PHECODE202.2_GWAS-Catalog-r2019-05-03-X202.2_PT_UKB_20200608)
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Non-Hodgkin's lymphoma non-Hodgkins lymphoma 10
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000642/ScoringFiles/PGS000642.txt.gz
PGS000643
(PRSWEB_PHECODE202.21_C-FOLLICULAR-LYMPHOMA_PRS-CS_MGI_20200608)
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Nodular lymphoma follicular lymphoma 1,048,780
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000643/ScoringFiles/PGS000643.txt.gz
PGS000644
(PRSWEB_PHECODE202.21_C-FOLLICULAR-LYMPHOMA_LASSOSUM_MGI_20200608)
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Nodular lymphoma follicular lymphoma 2,209,179
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000644/ScoringFiles/PGS000644.txt.gz
PGS000646
(PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_P_5e-08_MGI_20200608)
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Chronic lymphocytic leukemia chronic lymphocytic leukemia 32
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000646/ScoringFiles/PGS000646.txt.gz
PGS000647
(PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_P_5e-08_UKB_20200608)
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Chronic lymphocytic leukemia chronic lymphocytic leukemia 32
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000647/ScoringFiles/PGS000647.txt.gz
PGS000648
(PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_PT_MGI_20200608)
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Chronic lymphocytic leukemia chronic lymphocytic leukemia 44
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000648/ScoringFiles/PGS000648.txt.gz
PGS000649
(PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_PT_UKB_20200608)
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Chronic lymphocytic leukemia chronic lymphocytic leukemia 27
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000649/ScoringFiles/PGS000649.txt.gz
PGS000650
(PRSWEB_PHECODE204.12_UKBB-SAIGE-HRC-X204.12_PT_MGI_20200608)
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Chronic lymphocytic leukemia chronic lymphocytic leukemia 6
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000650/ScoringFiles/PGS000650.txt.gz
PGS000651
(PRSWEB_PHECODE204.12_UKBB-SAIGE-HRC-X204.12_LASSOSUM_MGI_20200608)
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Chronic lymphocytic leukemia chronic lymphocytic leukemia 76
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000651/ScoringFiles/PGS000651.txt.gz
PGS000791
(CC_NHL_IV)
PGP000186 |
Kachuri L et al. Nat Commun (2020)
Non-Hodgkin's lymphoma non-Hodgkins lymphoma 19
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000791/ScoringFiles/PGS000791.txt.gz
PGS000874
(PRS41_CLL)
PGP000220 |
Kleinstern G et al. Blood (2018)
Chronic lymphocytic leukemia chronic lymphocytic leukemia 41
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000874/ScoringFiles/PGS000874.txt.gz
PGS002303
(PRS9_DLBCL)
PGP000328 |
Choi J et al. Int J Cancer (2020)
Diffuse large B-cell lymphoma diffuse large B-cell lymphoma 9
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002303/ScoringFiles/PGS002303.txt.gz
PGS002304
(PRS6_FL)
PGP000328 |
Choi J et al. Int J Cancer (2020)
Follicular lymphoma follicular lymphoma 6
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002304/ScoringFiles/PGS002304.txt.gz
PGS003448
(PRS15_ALL)
PGP000448 |
Berndt SI et al. Leukemia (2022)
Acute lymphoblastic leukemia acute lymphoblastic leukemia 15
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003448/ScoringFiles/PGS003448.txt.gz
PGS003451
(PRS2_MZL)
PGP000448 |
Berndt SI et al. Leukemia (2022)
Marginal zone lymphoma marginal zone B-cell lymphoma 2
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003451/ScoringFiles/PGS003451.txt.gz
PGS003452
(PRS2_WM)
PGP000448 |
Berndt SI et al. Leukemia (2022)
Waldenström macroglobulinemia Waldenstrom macroglobulinemia 2
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003452/ScoringFiles/PGS003452.txt.gz
PGS003453
(PRS43_CLL)
PGP000448 |
Berndt SI et al. Leukemia (2022)
Chronic lymphocytic leukemia chronic lymphocytic leukemia 43
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003453/ScoringFiles/PGS003453.txt.gz
PGS003454
(PRS5_DLBCL)
PGP000448 |
Berndt SI et al. Leukemia (2022)
Diffuse large B-cell lymphoma diffuse large B-cell lymphoma 5
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003454/ScoringFiles/PGS003454.txt.gz
PGS003455
(PRS7_FL)
PGP000448 |
Berndt SI et al. Leukemia (2022)
Follicular lymphoma follicular lymphoma 7
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003455/ScoringFiles/PGS003455.txt.gz
PGS004248
(PRS20_nhl)
PGP000542 |
Kim ES et al. NPJ Precis Oncol (2023)
Non-Hodgkin's lymphoma non-Hodgkins lymphoma 20
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004248/ScoringFiles/PGS004248.txt.gz

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
Evaluated Score PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM000200 PGS000080
(CC_NHL)
PSS000119|
European Ancestry|
412,765 individuals
PGP000050 |
Graff RE et al. Nat Commun (2021)
Reported Trait: Non-Hodgkin's lymphoma OR: 1.25 [1.2, 1.3] Genotyping reagent kit (GERA cohort only), genotyping array (UK Biobank only), age, sex, 10 PCs. Results from meta-analysis of GERA and UKB
PPM002046 PGS000080
(CC_NHL)
PSS001019|
European Ancestry|
391,968 individuals
PGP000186 |
Kachuri L et al. Nat Commun (2020)
|Ext.
Reported Trait: Incident non-hodgkin's lymphoma HR: 1.16 [1.09, 1.24] AUROC: 0.677
C-index: 0.676 (0.01)
Age at assessment, sex, genotyping array, PCs(1-15) C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years.
PPM017168 PGS000080
(CC_NHL)
PSS010148|
European Ancestry|
721 individuals
PGP000443 |
Byrne S et al. Int J Epidemiol (2023)
|Ext.
Reported Trait: Non-Hodgkin's lymphoma HR: 1.19 [1.11, 1.28] age at baseline, sex (where relevant), assessment centre, 40 principal components of ancestries (PCs), Townsend Index, education, birth location, income, lifestyle index, additional cancer-specific covariates
PPM001326 PGS000641
(PRSWEB_PHECODE202.2_GWAS-Catalog-r2019-05-03-X202.2_P_5e-08_UKB_20200608)
PSS000580|
European Ancestry|
9,952 individuals
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Reported Trait: Non-Hodgkins lymphoma OR: 1.211 [1.133, 1.294]
β: 0.191 (0.034)
AUROC: 0.541 [0.521, 0.561] Nagelkerke's Pseudo-R²: 0.00682
Brier score: 0.0821
Odds Ratio (OR, top 1% vs. Rest): 2.05 [1.24, 3.4]
age, sex, batch PCs 1-4 Cancer PRSweb PheWAS Results: PRSWEB_PHECODE202.2_GWAS-Catalog-r2019-05-03-X202.2_P_5e-08_UKB_20200608
PPM001327 PGS000642
(PRSWEB_PHECODE202.2_GWAS-Catalog-r2019-05-03-X202.2_PT_UKB_20200608)
PSS000580|
European Ancestry|
9,952 individuals
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Reported Trait: Non-Hodgkins lymphoma OR: 1.239 [1.16, 1.324]
β: 0.214 (0.0337)
AUROC: 0.547 [0.527, 0.566] Nagelkerke's Pseudo-R²: 0.0087
Brier score: 0.082
Odds Ratio (OR, top 1% vs. Rest): 2.05 [1.24, 3.4]
age, sex, batch PCs 1-4 Cancer PRSweb PheWAS Results: PRSWEB_PHECODE202.2_GWAS-Catalog-r2019-05-03-X202.2_PT_UKB_20200608
PPM001328 PGS000643
(PRSWEB_PHECODE202.21_C-FOLLICULAR-LYMPHOMA_PRS-CS_MGI_20200608)
PSS000560|
European Ancestry|
3,256 individuals
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Reported Trait: Nodular lymphoma OR: 1.133 [1.005, 1.277]
β: 0.125 (0.061)
AUROC: 0.532 [0.497, 0.568] Nagelkerke's Pseudo-R²: 0.00282
Brier score: 0.0825
Odds Ratio (OR, top 1% vs. Rest): 2.49 [1.1, 5.65]
age, sex, batch PCs 1-4 Cancer PRSweb PheWAS Results: PRSWEB_PHECODE202.21_C-FOLLICULAR-LYMPHOMA_PRS-CS_MGI_20200608
PPM001329 PGS000644
(PRSWEB_PHECODE202.21_C-FOLLICULAR-LYMPHOMA_LASSOSUM_MGI_20200608)
PSS000560|
European Ancestry|
3,256 individuals
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Reported Trait: Nodular lymphoma OR: 1.149 [1.021, 1.294]
β: 0.139 (0.0606)
AUROC: 0.538 [0.504, 0.573] Nagelkerke's Pseudo-R²: 0.00349
Brier score: 0.0825
Odds Ratio (OR, top 1% vs. Rest): 1.48 [0.538, 4.05]
age, sex, batch PCs 1-4 Cancer PRSweb PheWAS Results: PRSWEB_PHECODE202.21_C-FOLLICULAR-LYMPHOMA_LASSOSUM_MGI_20200608
PPM001331 PGS000646
(PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_P_5e-08_MGI_20200608)
PSS000561|
European Ancestry|
756 individuals
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Reported Trait: Lymphoid leukemia, chronic OR: 2.104 [1.628, 2.718]
β: 0.744 (0.131)
AUROC: 0.696 [0.628, 0.765] Nagelkerke's Pseudo-R²: 0.0973
Brier score: 0.0779
Odds Ratio (OR, top 1% vs. Rest): 11.3 [3.76, 33.9]
age, sex, batch PCs 1-4 Cancer PRSweb PheWAS Results: PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_P_5e-08_MGI_20200608
PPM001332 PGS000647
(PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_P_5e-08_UKB_20200608)
PSS000581|
European Ancestry|
2,758 individuals
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Reported Trait: Lymphoid leukemia, chronic OR: 1.874 [1.639, 2.144]
β: 0.628 (0.0685)
AUROC: 0.675 [0.64, 0.707] Nagelkerke's Pseudo-R²: 0.0689
Brier score: 0.0795
Odds Ratio (OR, top 1% vs. Rest): 4.11 [1.97, 8.6]
age, sex, batch PCs 1-4 Cancer PRSweb PheWAS Results: PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_P_5e-08_UKB_20200608
PPM001333 PGS000648
(PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_PT_MGI_20200608)
PSS000561|
European Ancestry|
756 individuals
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Reported Trait: Lymphoid leukemia, chronic OR: 2.124 [1.648, 2.738]
β: 0.753 (0.13)
AUROC: 0.696 [0.621, 0.764] Nagelkerke's Pseudo-R²: 0.102
Brier score: 0.0776
Odds Ratio (OR, top 1% vs. Rest): 12.9 [4.45, 37.6]
age, sex, batch PCs 1-4 Cancer PRSweb PheWAS Results: PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_PT_MGI_20200608
PPM001334 PGS000649
(PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_PT_UKB_20200608)
PSS000581|
European Ancestry|
2,758 individuals
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Reported Trait: Lymphoid leukemia, chronic OR: 1.85 [1.619, 2.114]
β: 0.615 (0.0681)
AUROC: 0.672 [0.637, 0.703] Nagelkerke's Pseudo-R²: 0.0665
Brier score: 0.0796
Odds Ratio (OR, top 1% vs. Rest): 2.52 [1.04, 6.08]
age, sex, batch PCs 1-4 Cancer PRSweb PheWAS Results: PRSWEB_PHECODE204.12_GWAS-Catalog-r2019-05-03-X204.12_PT_UKB_20200608
PPM001335 PGS000650
(PRSWEB_PHECODE204.12_UKBB-SAIGE-HRC-X204.12_PT_MGI_20200608)
PSS000561|
European Ancestry|
756 individuals
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Reported Trait: Lymphoid leukemia, chronic OR: 1.368 [1.097, 1.705]
β: 0.313 (0.113)
AUROC: 0.577 [0.511, 0.645] Nagelkerke's Pseudo-R²: 0.0205
Brier score: 0.0822
Odds Ratio (OR, top 1% vs. Rest): 2.0 [0.308, 13.0]
age, sex, batch PCs 1-4 Cancer PRSweb PheWAS Results: PRSWEB_PHECODE204.12_UKBB-SAIGE-HRC-X204.12_PT_MGI_20200608
PPM001336 PGS000651
(PRSWEB_PHECODE204.12_UKBB-SAIGE-HRC-X204.12_LASSOSUM_MGI_20200608)
PSS000561|
European Ancestry|
756 individuals
PGP000118 |
Fritsche LG et al. Am J Hum Genet (2020)
Reported Trait: Lymphoid leukemia, chronic OR: 1.32 [1.041, 1.675]
β: 0.278 (0.121)
AUROC: 0.573 [0.503, 0.644] Nagelkerke's Pseudo-R²: 0.0145
Brier score: 0.0823
Odds Ratio (OR, top 1% vs. Rest): 4.84 [1.23, 19.0]
age, sex, batch PCs 1-4 Cancer PRSweb PheWAS Results: PRSWEB_PHECODE204.12_UKBB-SAIGE-HRC-X204.12_LASSOSUM_MGI_20200608
PPM002062 PGS000791
(CC_NHL_IV)
PSS001019|
European Ancestry|
391,968 individuals
PGP000186 |
Kachuri L et al. Nat Commun (2020)
Reported Trait: Incident non-hodgkin's lymphoma HR: 1.15 [1.08, 1.22] AUROC: 0.677
C-index: 0.674 (0.01)
: 0.227 Age at assessment, sex, genotyping array, PCs(1-15) C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years.
PPM002493 PGS000874
(PRS41_CLL)
PSS001123|
Multi-ancestry (including European)|
3,958 individuals
PGP000220 |
Kleinstern G et al. Blood (2018)
Reported Trait: Chronic lymphocytic leukemia OR: 2.49 [2.28, 2.8] C-index: 0.79 [0.78, 0.8] Age, sex, study, socioeconomic status (when available) Odds Ratio (OR, top 20% vs middle 20%) = 3.64 [2.94 - 4.51]
PPM002494 PGS000874
(PRS41_CLL)
PSS001123|
Multi-ancestry (including European)|
3,958 individuals
PGP000220 |
Kleinstern G et al. Blood (2018)
Reported Trait: Chronic lymphocytic leukemia in individuals with no family history of hematological cancers OR: 2.46 [2.19, 2.76] C-index: 0.791 [0.77, 0.81] Age, sex, study, socioeconomic status (when available) Odds Ratio (OR, top 20% vs middle 20%) = 3.29 [2.49 - 4.35]
PPM002495 PGS000874
(PRS41_CLL)
PSS001123|
Multi-ancestry (including European)|
3,958 individuals
PGP000220 |
Kleinstern G et al. Blood (2018)
Reported Trait: Chronic lymphocytic leukemia in individuals with a family history of hematological cancers OR: 3.79 [2.44, 5.87] C-index: 0.861 [0.82, 0.9] Age, sex, study, socioeconomic status (when available) Odds Ratio (OR, top 20% vs middle 20%) = 7.58 [2.74 - 21.0]
PPM002496 PGS000874
(PRS41_CLL)
PSS001121|
Ancestry Not Reported|
218 individuals
PGP000220 |
Kleinstern G et al. Blood (2018)
Reported Trait: Chronic lymphocytic leukemia OR: 2.44 [1.65, 3.62] C-index: 0.798 [0.74, 0.85] Age, sex, study, socioeconomic status (when available) Odds Ratio (OR, top 20% vs middle 20%) = 3.51 [1.39 - 8.86]
PPM002497 PGS000874
(PRS41_CLL)
PSS001122|
Ancestry Not Reported|
153 individuals
PGP000220 |
Kleinstern G et al. Blood (2018)
Reported Trait: Monoclonal B-cell lymphocytosis OR: 2.3 [1.44, 3.67] C-index: 0.773 [0.7, 0.85] Age, sex, study, socioeconomic status (when available) Odds Ratio (OR, top 20% vs middle 20%) = 4.36 [1.45 - 13.1]
PPM002498 PGS000874
(PRS41_CLL)
PSS001119|
Ancestry Not Reported|
1,468 individuals
PGP000220 |
Kleinstern G et al. Blood (2018)
Reported Trait: Chronic lymphocytic leukemia OR: 3.02 [2.49, 3.65] C-index: 0.779 [0.74, 0.81] Age, sex Odds Ratio (OR, top 20% vs middle 20%) = 4.47 [2.76 - 7.24]
PPM002499 PGS000874
(PRS41_CLL)
PSS001120|
Ancestry Not Reported|
1,362 individuals
PGP000220 |
Kleinstern G et al. Blood (2018)
Reported Trait: Monoclonal B-cell lymphocytosis OR: 2.81 [2.18, 3.61] C-index: 0.774 [0.73, 0.82] Age, sex Odds Ratio (OR, top 20% vs middle 20%) = 4.34 [2.21 - 8.50]
PPM002654 PGS000874
(PRS41_CLL)
PSS001173|
European Ancestry|
3,191 individuals
PGP000234 |
Kleinstern G et al. Leukemia (2021)
|Ext.
Reported Trait: Monoclonal B-cell lymphocytosis OR: 1.86 [1.67, 2.07] C-index: 0.72 [0.69, 0.73] Odds Ratio (OR, top 20% vs middle 20%): 2.38 [1.81, 3.13] Age, sex
PPM002655 PGS000874
(PRS41_CLL)
PSS001173|
European Ancestry|
3,191 individuals
PGP000234 |
Kleinstern G et al. Leukemia (2021)
|Ext.
Reported Trait: Monoclonal B-cell lymphocytosis OR: 1.15 [1.13, 1.18] C-index: 0.72 [0.7, 0.74] Age, sex An unweighted version of PRS41_CLL was used.
PPM002656 PGS000874
(PRS41_CLL)
PSS001173|
European Ancestry|
3,191 individuals
PGP000234 |
Kleinstern G et al. Leukemia (2021)
|Ext.
Reported Trait: Low-count monoclonal B-cell lymphocytosis OR: 1.75 [1.55, 1.98] C-index: 0.72 [0.7, 0.75] Odds Ratio (OR, top 20% vs middle 20%): 2.1 [1.53, 2.88] Age, sex
PPM002657 PGS000874
(PRS41_CLL)
PSS001173|
European Ancestry|
3,191 individuals
PGP000234 |
Kleinstern G et al. Leukemia (2021)
|Ext.
Reported Trait: Low-count monoclonal B-cell lymphocytosis OR: 1.14 [1.11, 1.17] C-index: 0.72 [0.7, 0.75] Age, sex An unweighted version of PRS41_CLL was used.
PPM002658 PGS000874
(PRS41_CLL)
PSS001173|
European Ancestry|
3,191 individuals
PGP000234 |
Kleinstern G et al. Leukemia (2021)
|Ext.
Reported Trait: High-count monoclonal B-cell lymphocytosis OR: 2.14 [1.8, 2.56] C-index: 0.73 [0.69, 0.77] Odds Ratio (OR, top 20% vs middle 20%): 3.13 [1.97, 4.98] Age, sex
PPM002659 PGS000874
(PRS41_CLL)
PSS001173|
European Ancestry|
3,191 individuals
PGP000234 |
Kleinstern G et al. Leukemia (2021)
|Ext.
Reported Trait: High-count monoclonal B-cell lymphocytosis OR: 1.19 [1.14, 1.23] C-index: 0.725 [0.69, 0.77] Age, sex An unweighted version of PRS41_CLL was used.
PPM002660 PGS000874
(PRS41_CLL)
PSS001172|
European Ancestry|
3,327 individuals
PGP000234 |
Kleinstern G et al. Leukemia (2021)
|Ext.
Reported Trait: Chronic lymphocytic leukemia OR: 2.53 [2.27, 2.81] C-index: 0.77 [0.75, 0.79] Odds Ratio (OR, top 20% vs middle 20%): 3.49 [2.70, 4.51] Age, sex
PPM002661 PGS000874
(PRS41_CLL)
PSS001172|
European Ancestry|
3,327 individuals
PGP000234 |
Kleinstern G et al. Leukemia (2021)
|Ext.
Reported Trait: Chronic lymphocytic leukemia OR: 1.23 [1.2, 1.26] C-index: 0.775 [0.76, 0.79] Age, sex An unweighted version of PRS41_CLL was used.
PPM002662 PGS000874
(PRS41_CLL)
PSS001171|
African Ancestry|
408 individuals
PGP000234 |
Kleinstern G et al. Leukemia (2021)
|Ext.
Reported Trait: Chronic lymphocytic leukemia OR: 1.76 [1.34, 2.31] C-index: 0.62 [0.57, 0.68] Age, sex
PPM002663 PGS000874
(PRS41_CLL)
PSS001171|
African Ancestry|
408 individuals
PGP000234 |
Kleinstern G et al. Leukemia (2021)
|Ext.
Reported Trait: Chronic lymphocytic leukemia OR: 1.07 [1.01, 1.13] C-index: 0.57 [0.53, 0.64] Age, sex An unweighted version of PRS41_CLL was used.
PPM013032 PGS002303
(PRS9_DLBCL)
PSS009657|
European Ancestry|
308 individuals
PGP000328 |
Choi J et al. Int J Cancer (2020)
Reported Trait: Diffuse large B-cell lymphoma AUROC: 0.56 [0.53, 0.6]
PPM013040 PGS002303
(PRS9_DLBCL)
PSS009657|
European Ancestry|
308 individuals
PGP000328 |
Choi J et al. Int J Cancer (2020)
Reported Trait: Diffuse large B-cell lymphoma Hazard ratio (HR top 5% vs average): 1.6 [1.01, 2.54] Age, birth cohort, genotyping array, top 10 PCs for ancestry and sex (for nonsex specific cancer only)
PPM013033 PGS002304
(PRS6_FL)
PSS009658|
European Ancestry|
197 individuals
PGP000328 |
Choi J et al. Int J Cancer (2020)
Reported Trait: Follicular lymphoma AUROC: 0.61 [0.59, 0.63]
PPM013041 PGS002304
(PRS6_FL)
PSS009658|
European Ancestry|
197 individuals
PGP000328 |
Choi J et al. Int J Cancer (2020)
Reported Trait: Follicular lymphoma Hazard ratio (HR top 5% vs average): 2.33 [1.38, 3.93] Age, birth cohort, genotyping array, top 10 PCs for ancestry and sex (for nonsex specific cancer only)
PPM017230 PGS003448
(PRS15_ALL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Chronic lymphocytic leukemia OR: 0.95 [0.9, 1.0]
PPM017238 PGS003448
(PRS15_ALL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Diffuse large B-cell lymphoma OR: 0.99 [0.94, 1.04]
PPM017246 PGS003448
(PRS15_ALL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Follicular lymphoma OR: 1.01 [0.95, 1.06]
PPM017254 PGS003448
(PRS15_ALL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Marginal zone lymphoma OR: 1.02 [0.93, 1.12]
PPM017227 PGS003451
(PRS2_MZL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Chronic lymphocytic leukemia OR: 1.26 [1.09, 1.46]
PPM017235 PGS003451
(PRS2_MZL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Diffuse large B-cell lymphoma OR: 1.53 [1.34, 1.75]
PPM017243 PGS003451
(PRS2_MZL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Follicular lymphoma OR: 1.39 [1.21, 1.61]
PPM017251 PGS003451
(PRS2_MZL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Marginal zone lymphoma OR: 2.43 [1.93, 3.06]
PPM017228 PGS003452
(PRS2_WM)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Chronic lymphocytic leukemia OR: 1.07 [1.01, 1.14]
PPM017236 PGS003452
(PRS2_WM)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Diffuse large B-cell lymphoma OR: 1.24 [1.18, 1.31]
PPM017244 PGS003452
(PRS2_WM)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Follicular lymphoma OR: 1.12 [1.05, 1.19]
PPM017252 PGS003452
(PRS2_WM)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Marginal zone lymphoma OR: 1.18 [1.07, 1.3]
PPM017224 PGS003453
(PRS43_CLL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Chronic lymphocytic leukemia OR: 2.17 [2.07, 2.28]
PPM017232 PGS003453
(PRS43_CLL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Diffuse large B-cell lymphoma OR: 1.17 [1.12, 1.22]
PPM017240 PGS003453
(PRS43_CLL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Follicular lymphoma OR: 1.12 [1.07, 1.17]
PPM017248 PGS003453
(PRS43_CLL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Marginal zone lymphoma OR: 1.15 [1.07, 1.24]
PPM017225 PGS003454
(PRS5_DLBCL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Chronic lymphocytic leukemia OR: 1.33 [1.14, 1.54]
PPM017233 PGS003454
(PRS5_DLBCL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Diffuse large B-cell lymphoma OR: 2.69 [2.35, 3.08]
PPM017249 PGS003454
(PRS5_DLBCL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Marginal zone lymphoma OR: 2.1 [1.63, 2.72]
PPM017241 PGS003454
(PRS5_DLBCL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Follicular lymphoma OR: 1.66 [1.42, 1.94]
PPM017226 PGS003455
(PRS7_FL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Chronic lymphocytic leukemia OR: 1.07 [0.98, 1.17]
PPM017234 PGS003455
(PRS7_FL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Diffuse large B-cell lymphoma OR: 1.28 [1.19, 1.39]
PPM017242 PGS003455
(PRS7_FL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Follicular lymphoma OR: 2.77 [2.52, 3.04]
PPM017250 PGS003455
(PRS7_FL)
PSS010176|
European Ancestry|
20,134 individuals
PGP000448 |
Berndt SI et al. Leukemia (2022)
Reported Trait: Marginal zone lymphoma OR: 0.94 [0.81, 1.09]
PPM020305 PGS004248
(PRS20_nhl)
PSS011328|
European Ancestry|
133,830 individuals
PGP000542 |
Kim ES et al. NPJ Precis Oncol (2023)
Reported Trait: Non-Hodgkin's lymphoma HR: 1.16 [1.03, 1.3] first 10 genetic principal components
PPM020313 PGS004248
(PRS20_nhl)
PSS011329|
European Ancestry|
115,207 individuals
PGP000542 |
Kim ES et al. NPJ Precis Oncol (2023)
Reported Trait: Non-Hodgkin's lymphoma HR: 1.22 [1.1, 1.36] first 10 genetic principal components

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS000560 PheCode:202.21; ICD9CM:202.00, 202.01, 202.02, 202.03, 202.04, 202.05, 202.06, 202.07, 202.08; ICD10CM:C82, C82.0, C82.00, C82.01, C82.02, C82.03, C82.04, C82.05, C82.06, C82.07, C82.08, C82.09, C82.1, C82.10, C82.11, C82.12, C82.13, C82.14, C82.15, C82.16, C82.17, C82.18, C82.19, C82.2, C82.20, C82.21, C82.22, C82.23, C82.24, C82.25, C82.26, C82.27, C82.28, C82.29, C82.3, C82.30, C82.31, C82.32, C82.33, C82.34, C82.35, C82.36, C82.37, C82.38, C82.39, C82.4, C82.40, C82.41, C82.42, C82.43, C82.44, C82.45, C82.46, C82.47, C82.48, C82.49, C82.5, C82.50, C82.51, C82.52, C82.53, C82.54, C82.55, C82.56, C82.57, C82.58, C82.59, C82.6, C82.60, C82.61, C82.62, C82.63, C82.64, C82.65, C82.66, C82.67, C82.68, C82.69, C82.8, C82.80, C82.81, C82.82, C82.83, C82.84, C82.85, C82.86, C82.87, C82.88, C82.89, C82.9, C82.90, C82.91, C82.92, C82.93, C82.94, C82.95, C82.96, C82.97, C82.98, C82.99
[
  • 296 cases
  • , 2,960 controls
]
European MGI
PSS000561 PheCode:204.12; ICD9CM:204.10, 204.11, 204.12; ICD10CM:C91.1, C91.10, C91.11, C91.12
[
  • 69 cases
  • , 687 controls
]
European MGI
PSS010176
[
  • 10,629 cases
  • , 9,505 controls
]
European NR Inter- Lymph Consortium
PSS011328 133,830 individuals,
0.0 % Male samples
European
(British)
UKB
PSS011329 115,207 individuals,
100.0 % Male samples
European
(British)
UKB
PSS000580 PheCode:202.2; ICD9:200, 200.2, 200.8, 202.1, 202.2, 202.8, 202.9; ICD10:B21.1, C82.0, C82.1, C82.2, C82.7, C82.9, C83.0, C83.1, C83.2, C83.3, C83.4, C83.5, C83.6, C83.7, C83.8, C83.9, C84.0, C84.1, C84.2, C84.3, C84.4, C84.5, C85.0, C85.1, C85.7, C85.9, C96.7, C96.9, L41.2
[
  • 901 cases
  • , 9,051 controls
]
European UKB
PSS000581 PheCode:204.12; ICD9:204.1; ICD10:C91.1
[
  • 249 cases
  • , 2,509 controls
]
European UKB
PSS010148
[
  • 61 cases
  • , 660 controls
]
European UKB
PSS001171 Cases were individuals with chronic lymphocytic leukemia (CLL). CLL diagnoses were made based on the 1996 NCI working group criteria and updated to the 2008 International Workshop CLL criteria wherever possible.
[
  • 173 cases
  • , 235 controls
]
,
66.91 % Male samples
African American or Afro-Caribbean MAYO Possibly significant sample overlap between this dataset and the dataset used to source PRS41_CLL. Additional cases were obtained from Duke University and Cornell
PSS001172 Cases were individuals with chronic lymphocytic leukemia (CLL). CLL diagnoses were made based on the 1996 NCI working group criteria and updated to the 2008 International Workshop CLL criteria wherever possible.
[
  • 696 cases
  • , 2,631 controls
]
,
45.36 % Male samples
European MAYO Possibly significant sample overlap between this dataset and the dataset used to source PRS41_CLL. Additional cases were obtained from Duke University and Cornell
PSS001173 Cases were individuals with monoclonal B-cell lymphocytosis (MBL) from two Mayo Clincs.Within the Mayo Clinic Biobank, MBL was screened for using a highly sensitive, 8-color (CD38, CD45, Kappa, Lambda, CD19, CD23, CD5 and CD20) flow-cytometry assay with the capacity to detect clonal B-cell counts to the 0.005% level (1/20,000 events), and for each individual, 500,000 PBMC events were typically captured. Of the 560 MBL cases, 396 had low-count MBL (LC-MBL) and 164 had high-count MBL (HC-MBL). Wiithin the Mayo Clinic Biobank only a subset of participants had a complete blood count. therefore the percent of clonal B-cells out of total B-cells was used to categorize participants as LC- and HC-MBL. Based on prior evidence, those MBL individuals with a percent clonal B-cell <85% were defined as LC-MBL and those with percent clonal B-cells ≥85% as HC-MBL. Within the Mayo Clinic Chronic lymphocytic leukemia (CLL) Resource, MBL was classified by LC-MBL or HC-MBL according to the B-cell clone size of below or above 0.5 × 109/L threshold, respectively.
[
  • 560 cases
  • , 2,631 controls
]
,
42.28 % Male samples
European MAYO Possibly significant sample overlap between this dataset and the dataset used to source PRS41_CLL.
PSS009657 diffuse large B-cell lymphoma (ICD-10 = C83.3) 308 individuals European UKB
PSS009658 follicular lymphoma (ICD- 10 = C82 or ICD-O: 9690) 197 individuals European UKB
PSS001119 Cases were individuals with chronic lymphocytic leukemia.
[
  • 201 cases
  • , 1,267 controls
]
Not reported MAYO Cases were obtained from the Genetic Epidemiology of CLL (GEC) Consortium
PSS001120 Cases were individuals with monoclonal B-cell lymphocytosis.
[
  • 95 cases
  • , 1,267 controls
]
Not reported MAYO Cases were obtained from the Genetic Epidemiology of CLL (GEC) Consortium
PSS001121 Cases were individuals with chronic lymphocytic leukemia.
[
  • 135 cases
  • , 83 controls
]
Not reported NR Cases and controls were obtained from the Genetic Epidemiology of CLL (GEC) Consortium
PSS001122 Cases were individuals with monoclonal B-cell lymphocytosis.
[
  • 95 cases
  • , 58 controls
]
Not reported NR Cases and controls were obtained from the Genetic Epidemiology of CLL (GEC) Consortium
PSS001123 Cases were individuals with chronic lymphocytic leukemia (CLL). Of the 3,958 individuals, 242 had a family history (FH) of hematological cancers, whereas 2,409 had no FH of hematological cancers. Of the 242 individuals with a FH, 112 had CLL. Of the 2,409 without a FH, 783 had CLL. FH was defined as a person self-reporting any hematological maligcancy among first-degree relatives. Hematological malignancies were defined as any non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, or leukemia.
[
  • 1,499 cases
  • , 2,459 controls
]
,
60.81 % Male samples
European, NR 8 cohorts
  • BC
  • ,ENGELA
  • ,EpiLymph
  • ,MAYO
  • ,NCI-SEER
  • ,NSW
  • ,SCALE
  • ,UCSF2
Possible significant sample overlap between this dataset and the dataset used to source PRS41_CLL.
PSS001019 Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases.
[
  • 970 cases
  • , 390,998 controls
]
European UKB
PSS000119 Cancer diagnoses were obtained from reigstry data in GERA, and ICD-9/10 codes mapped to ICD-O-3 codes in UK Biobank. Cancers for this phenotype were classified using the following SEER site recode(s): 33041, and 33042
[
  • 2,411 cases
  • , 410,354 controls
]
,
46.0 % Male samples
Mean = 58.0 years European GERA, UKB